Amanda Waltemath, Director of Clinical Services joins a panel discussion on April 10th, and Tate Rice, Director of Product Management speaks to Risk & Insurance.
Novel migraine agents are continuing to enter the market, providing alternative forms of pain relief for migraine sufferers. What are the efficacy and cost considerations for injured workers?